Medicare Procedure and Patient Information
2015 Medicare Patient Data
Information about Medicare patients treated by Dr. Andrew L. Feldman, MD.
| Non-Hispanic White | |
|---|---|
| Black | |
| Hispanic | |
| Asian | |
| Other | |
| Native American |
(No ratings)
Dr. Andrew L. Feldman, MD is a hematopathologist in Rochester, MN specializing in hematopathology. He graduated from Brown University, Alpert Medical School in 1991 and has 34 years of experience. Dr. Andrew L. Feldman, MD is affiliated with Mayo Clinic.
Click on any procedure below to see further details on volume and pricing among Medicare patients.
In 2023, Dr. Andrew L. Feldman, MD had a list price for genetic testing that was lower than the list prices billed to Medicare by 95% of providers in related specialties within Minnesota. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
Information about Medicare patients treated by Dr. Andrew L. Feldman, MD.
| Non-Hispanic White | 26 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
Information about Medicare patients treated by Dr. Andrew L. Feldman, MD.
| Non-Hispanic White | 22 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
The most common conditions of Medicare patients that Dr. Andrew L. Feldman, MD treated during 2018 were hypertension, high cholesterol and ischemic heart disease.
| Hypertension | 73 |
|---|---|
| High Cholesterol | 59 |
| Stroke | 0 |
| Ischemic Heart Disease | 55 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
The most common conditions of Medicare patients that Dr. Andrew L. Feldman, MD treated during 2020 were hypertension and chronic kidney disease.
| Hypertension | 75 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 65 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
The top procedures that Dr. Andrew L. Feldman, MD treated as a hematopathologist in Rochester, MN during 2021 were second opinions, lab tests and cytology.
Volume of procedures performed by Dr. Andrew L. Feldman, MD for Medicare patients.
| cytology | 11 |
|---|---|
| lab tests | 14 |
| second opinions | 27 |
Information about Medicare patients treated by Dr. Andrew L. Feldman, MD.
| Male | 58 |
|---|---|
| Female | 52 |
| From 65 to 74 | 76 |
|---|---|
| From 75 to 84 | 19 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Andrew L. Feldman, MD treated during 2021 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
| Hypertension | 63 |
|---|---|
| High Cholesterol | 58 |
| Stroke | 0 |
| Ischemic Heart Disease | 29 |
| Depression | 28 |
| Chronic Kidney Disease | 49 |
| Asthma | 0 |
| Osteoperosis | 13 |
| Atrial Fibrilation | 14 |
| Heart Failure | 22 |
| Chronic Obstructive Pulmonary Disease | 15 |
| Diabetes | 25 |
| Dementia | 13 |
| Cancer | 16 |
The top procedures that Dr. Andrew L. Feldman, MD treated as a hematopathologist in Rochester, MN during 2022 were lab tests and second opinions.
Volume of procedures performed by Dr. Andrew L. Feldman, MD for Medicare patients.
| lab tests | 15 |
|---|---|
| second opinions | 12 |
Information about Medicare patients treated by Dr. Andrew L. Feldman, MD.
| Male | 28 |
|---|---|
| Female | 24 |
| From 65 to 74 | 30 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Andrew L. Feldman, MD treated during 2022 were hypertension, high cholesterol, ischemic heart disease and diabetes.
| Hypertension | 71 |
|---|---|
| High Cholesterol | 67 |
| Stroke | 0 |
| Ischemic Heart Disease | 37 |
| Depression | 0 |
| Chronic Kidney Disease | 31 |
| Asthma | 0 |
| Osteoperosis | 23 |
| Atrial Fibrilation | 27 |
| Heart Failure | 27 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 33 |
| Dementia | 0 |
| Cancer | 0 |
The top procedures that Dr. Andrew L. Feldman, MD treated as a hematopathologist in Rochester, MN during 2023 were lab tests and second opinions.
Volume of procedures performed by Dr. Andrew L. Feldman, MD for Medicare patients.
| lab tests | 67 |
|---|---|
| second opinions | 16 |
Information about Medicare patients treated by Dr. Andrew L. Feldman, MD.
| Male | 74 |
|---|---|
| Female | 43 |
| From 65 to 74 | 67 |
|---|---|
| From 75 to 84 | 38 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Andrew L. Feldman, MD treated during 2023 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
| Hypertension | 70 |
|---|---|
| High Cholesterol | 68 |
| Stroke | 11 |
| Ischemic Heart Disease | 31 |
| Depression | 15 |
| Chronic Kidney Disease | 36 |
| Asthma | 9 |
| Osteoperosis | 11 |
| Atrial Fibrilation | 26 |
| Heart Failure | 23 |
| Chronic Obstructive Pulmonary Disease | 14 |
| Diabetes | 26 |
| Dementia | 0 |
| Cancer | 21 |
Volume of procedures performed by Dr. Andrew L. Feldman, MD for Medicare patients.
The highest averages for the top procedures that Dr. Andrew L. Feldman, MD treated as a hematopathologist in Rochester, MN were lab tests, second opinions and cytology.
| cytology | 11 |
|---|---|
| lab tests | 32 |
| second opinions | 18 |
Information about Medicare patients treated by Dr. Andrew L. Feldman, MD.
| Male | 26 |
|---|---|
| Female | 19 |
| Black / African American | 0 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 8 |
| Native American / Alaskan Native | 0 |
| Hispanic | 0 |
| Other | 0 |
| 75 to 84 | 9 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 0 |
| 65 to 74 | 28 |
The highest averages of the most common conditions of Medicare patients that Dr. Andrew L. Feldman, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
| Hypertension | 58 |
|---|---|
| High Cholesterol | 42 |
| Stroke | 1 |
| Ischemic Heart Disease | 25 |
| Depression | 7 |
| Chronic Kidney Disease | 30 |
| Asthma | 1 |
| Osteoporosis | 7 |
| Heart Failure | 12 |
| Chronic Obstructive Pulmonary Disease | 4 |
| Diabetes | 14 |
| Atrial Fibrillation | 11 |
| Cancer | 6 |
| Dementia | 2 |
Dr. Andrew L. Feldman, MD graduated from Brown University, Alpert Medical School in 1991. He completed residency at Boston Medical Center. He is certified by the Anatomic Pathology American Board of Pathology and has a state license in Minnesota.
Medical School: Brown University, Alpert Medical School (1991)
Residency: Boston Medical Center (1994)
Board Certification: Anatomic Pathology American Board of Pathology (2004)
Licensed In: Minnesota
Dr. Andrew L. Feldman, MD is associated with these hospitals and organizations:
Dr. Andrew L. Feldman, MD does not have any reviews yet, be the first to leave a review of Dr. Andrew L. Feldman, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Andrew L. Feldman, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Pfizer Inc. |
$6,818
$6,818 |
|
|---|---|---|
| Actelion Pharmaceuticals US, Inc. |
$1,521
$1,521 |
|
| Millennium Pharmaceuticals, Inc. |
$388
$388 |
|
| Seattle Genetics, Inc. |
$209
ADCETRIS $133 |
$77 |
| Celgene Corporation |
$74
$74 |
| Grant | $6,818 |
|---|---|
| Travel and Lodging | $1,841 |
| Food and Beverage | $351 |
Dr. Andrew L. Feldman, MD has received 2 research payments totaling $40,990.
Dr. Andrew Feldman practices hematopathology in Rochester, MN. His clinical interests encompass peripheral T-cell lymphoma and genetic issues. He is affiliated with Mayo Clinic. Dr. Feldman attended Brown University, Alpert Medical School and then went on to complete his residency at Waterbury Hospital, Boston Medical Center, and National Cancer Institute.